Arthritis

Disease State Hub

Slideshows

Slideshow

12/02/2023

This slideshow illustrates different types of arthritis featured in cases from the Consultant archives. Each slide links to the full case report for more details.

12/02/2023

Research Summaries

Research Summary

Fracture Risk Doubles For Patients With Acute Calcium Pyrophosphate Crystal Arthritis

02/08/2024

Anthony Calabro, MA

Researchers developed what is believed to be the first matched cohort study comparing the risk of fractures in patients with acute calcium pyrophosphate (CPP) crystal arthritis vs controls. The study was...

02/08/2024

FDA ALERT

FDA Approves First Biosimilar to Tocilizumab to Treat Adults, Pediatric Patients With Arthritis

11/15/2023

Jessica Ganga

In late September, the FDA approved the first biosimilar to tocilizumab to treat adult and pediatric patients with various indications of arthritis.

11/15/2023

Conference Coverage

Eosinophilia Common During IL-1, IL-6 Use in Patients With sJIA, non-sJIA

11/30/2022

The researchers examined the incidence rates, risk factors, and outcomes for IL-1 and IL-6 inhibitors in patients with systemic and non-systemic juvenile idiopathic arthritis.

11/30/2022

Conference Coverage

Use of IL-6 Receptor Inhibitors Increased in Patients With Adult Still Disease Following Approval of Intravenous Tocilizumab

11/27/2022

Researchers examined the treatment patterns in patients with adult Still disease in clinical practice and assessed changes in oral glucocorticoid dose after tocilizumab administration.

11/27/2022

Arthritis

FDA Approves Treatment Option for Polyarticular Course JIA

10/01/2020

A Janus kinase inhibitor was approved for the treatment of active polyarticular course juvenile idiopathic arthritis among patients aged 2 years or older.

10/01/2020

April 2024

Current Issue

April 2024

Volume 64

Issue 4